News for hackers. Stuff that matters.
Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by golergka on Wednesday April 26, 2017 @10:04AM (#14203027)
The current state of EpiPen is a direct result of free will of the original inventor and the company he worked for when he developed it. The company which is currently an "evil monopolist" acquired the rights to it as result of free-market, mutually beneficial transactions. Yes, they offer the tech for a lot of money - but you are _free_ not to purchase it and use older medicine instead.

The problem with your type of logic is illustrated best not by the complicated reality, but (as usual with philosophical problems) a corner case. Imagine that I invent a fantastic new medicine - and being an evil genius, leave it in my lab, never announcing it to the world, knowing perfectly well that millions of people around the world could be saved if I did.

In your logic, this absence of action makes me evil - although these poor sufferers would suffer just the same if I didn't invent this new medicine to begin with. The same is true for EpiPen: it's their inaction you condemn, not action.

The medical industry is not making the world a worse place through it's actions; it just isn't doing it a better place to an extent that you would want them to.

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by CPLX on Wednesday April 26, 2017 @10:34AM (#14203305)
> The same is true for EpiPen: it's their inaction you condemn, not action.

Your claim is factually incorrect. The issue here is specific, purposeful, anticompetitive behavior.

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by nkrisc on Wednesday April 26, 2017 @10:23AM (#14203189)
In your example I wouldn't go so far as to say you would be evil, perhaps just morally bankrupt or at the very least lacking in empathy.

You have someone like Jonas Salk who basically fit your example perfectly, except he decided to share his invention with the world instead of hiding it away as per your example.

You're free to not share your cure with the world, no one could force you, but I would question the motivations of someone who chose not to.

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by maxerickson on Wednesday April 26, 2017 @10:12AM (#14203092)
Mylan bought it after someone came up with a minor improvement to the needle cap and it could be marketed under a patent.

The ridiculous price has little to do with the original inventor.

A not stupid regulatory system would evaluate the value of the improvement to the market (likely hugely negative in this case). The idea wouldn't be to deny the company the right to the patent, it would be to deny regulatory approval for the patented version of the device.

(the argument being that decreased access to the patented device costs more than the benefit provided by the minor safety improvements it offers).

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by golergka on Wednesday April 26, 2017 @10:15AM (#14203116)
When you got a regulatory system that evaluates value, you got a complex, corruption and bug prone system.

I'd take my systems stupid and simple, please.

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by maxerickson on Wednesday April 26, 2017 @10:17AM (#14203137)
A simple implementation would force them to market the new pen under a different name.

They would of course argue that this confuses the marketplace. But they are sitting there exploiting the confused marketplace, so not much of an argument to be made along those lines.

Re:Mylan’s EpiPen price hike was a scheme to stifle competit... by HarryHirsch on Wednesday April 26, 2017 @10:18AM (#14203151)
There used to be a time when the monopolist would not raise price to whatever they could ge away with. Daraprim was very affordable for 50 years until Shkreli bought out the manufacturer, the same with Epipens, until Mylan bought the product from Merck KGA. One could easily find more examples if one went looking.

Something changed in ths mid-90s. Neoliberalism became salonfähig, or something.